US Vascular Delivery Devices and Accessories Market Almost Reached USD 4 Billion in 2012, According to iData Research26 Feb 2013 • by Natalie Aster
The market for vascular delivery devices and accessories in the United States grew by 6% over the previous year to nearly $4 billion. Market growth will be driven by a high incidence rate of cancer among the American public and government policies that encourage safer practices and products.
These vascular delivery devices have been used extensively for decades, and they represent an established and integrated component of patient care. The rise in demand for vascular access devices is proportional to the number of people who require medical care each year. As of 2011, the U.S. population was growing at approximately 0.7% per year, with the distribution shifting toward an older population due to declining mortality rates in the older demographic and reduced fertility rates in younger age groups.
According to the report “U.S. Market for Vascular Access Devices and Accessories” approximately 26% of Americans are obese, a statistic that is steadily increasing. As the population ages and this obesity rate grows, the number of people needing medical care and therefore vascular access devices or accessories will also rise. The hospitalization rate in the U.S. is expected to increase over the next few years. Despite its decline in previous years due to the economic recession, treatment in alternate care sites, such as clinics and nursing homes is expected to increase even more rapidly than the hospitalization rate.
U.S. Market for Vascular Access Devices and Accessories
Published: February, 2013
Price: US$ 2,013.00
“Our research finds that in recent years, there has been a concerted effort by U.S. government organizations, hospitals, medical companies and device manufacturers to decrease infections from central venous catheters (CVCs)” states Dr. Kamran Zamanian, CEO of iData Research. Catheters provide a direct route to the bloodstream for bacteria colonized around the insertion site and along the surface of the catheter. CVCs are commonly used for parenteral nutrition, blood transfusions, blood draws and medication and chemotherapy delivery. CVCs have long been the standard device used for gaining vascular access in emergency situations where patients require large volumes of fluids in short periods of time.
The Centers for Medicare and Medicaid Services (CMS) have stated that they will no longer reimburse treatments of vascular access–related infections, as they are preventable. Although antimicrobial coated and impregnated catheters are one way to reduce infections, this technology has not been readily accepted by clinicians, owing to a lack of clinical data validating the price premiums associated with these devices. Instead, catheter kits are including more accessories such as full-body drapes, manufactured securement devices and tip guidance capabilities. These additional features increase the ASP and the overall value of the market.
A number of new technologies are expected to drive the market for implantable ports. An interest in placing ports peripherally in locations that target specific cancer sites has also emerged. While implantable ports have the lowest infection rate of all vascular access devices, infections can become very serious if they are not diagnosed early or if a patient’s immune system is compromised. Improvements to ports such as this could make them a more attractive alternative and would create competition for Peripherally Inserted Central Catheters (PICCs) and chronic CVCs.
More information can be found in the report “U.S. Market for Vascular Access Devices and Accessories” by iData Research.
To order the report or ask for sample pages contact firstname.lastname@example.org